Skip to main content

Table 3 Effect of YGMM on T-SOD, GSH, and MDA levels in alcoholic liver injury of rats

From: Evaluation of the hepatoprotective effect of Yigan mingmu oral liquid against acute alcohol-induced liver injury in rats

Group

Liver

Kidney

 

T-SOD

(U/mg protein)

GSH

(mg/g protein)

MDA

(nmol/mg protein)

T-SOD

(U/mg protein)

GSH

(mg/g protein)

MDA

(nmol/mg protein)

Control

214.67 ± 22.34

3.32 ± 0.37

1.53 ± 0.20

127.90 ± 15.81

3.95 ± 0.19

0.88 ± 0.04

Alcohol

180.71 ± 5.71

2.43 ± 0.24#

1.57 ± 0.11

99.43 ± 4.17

3.39 ± 0.11#

0.77 ± 0.04

Silymarin

199.52 ± 6.48

2.91 ± 0.11

1.57 ± 0.16

86.15 ± 3.30

3.03 ± 0.14

1.22 ± 0.07***

YGMM (low dose)

220.10 ± 18.50

3.18 ± 0.23*

1.61 ± 0.13

100.47 ± 14.39

3.72 ± 0.16

0.86 ± 0.06

YGMM (medium dose)

209.49 ± 8.93

2.86 ± 0.22

1.70 ± 0.24

85.07 ± 3.31

3.05 ± 0.19

0.73 ± 0.08

YGMM (high dose)

210.86 ± 19.61

2.96 ± 0.03

1.83 ± 0.13

96.94 ± 4.12

3.42 ± 0.15

0.47 ± 0.10**

  1. Data are presented as mean ± SEM in each group. #p < 0.05 compared with the normal control group; *p < 0.05, **p < 0.01, ***p < 0.001 compared with the alcohol group